RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $236,000 | +90.3% | 544,238 | +4161.5% | 0.00% | +100.0% |
| Q4 2021 | $124,000 | -73.3% | 12,771 | -50.8% | 0.00% | -66.7% |
| Q3 2021 | $465,000 | -26.7% | 25,981 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $634,000 | -37.9% | 25,981 | -32.6% | 0.00% | -50.0% |
| Q1 2021 | $1,021,000 | -65.9% | 38,546 | -90.2% | 0.01% | -69.2% |
| Q4 2020 | $2,997,000 | +48.6% | 394,909 | -1.9% | 0.03% | +23.8% |
| Q3 2020 | $2,017,000 | -9.3% | 402,555 | +8.3% | 0.02% | -12.5% |
| Q2 2020 | $2,224,000 | – | 371,865 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |